This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...
An experimental gene therapy that involves injecting CRISPR therapy directly into visually impaired patients’ eyeballs has vastly improved most volunteers’ vision — even allowing some to see color ...
An investigational gene therapy has shown promise for improving functional vision and restoring light detection in long-dormant rods and cones in the retina in adults and children with a rare form of ...
Gene therapy scientists have long dreamed of curing blindness. The first commercial gene therapy in the US, Luxturna, was approved by the US Food and Drug Administration in 2017 to partially restore ...
The most common types of color blindness, or color vision deficiency, are genetic. However, other types may develop due to injuries, eye diseases, health problems, and side effects of treatment.
Color blindness, or color vision deficiency, causes a person to see colors differently from most other people. There are several types of color blindness. Color vision deficiency or loss has multiple ...
Two people with a rare inherited eye disorder have had their night vision restored by an experimental gene therapy, researchers say. These two individuals are part of an ongoing clinical trial testing ...
Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback